The correct answer is D.
The domain is the broadest category in the classification of living organisms. All the living organisms are placed in three domains, which are archaea, bacteria and eukaryotes. The prokaryotes are separated into two groups, that is archaea and bacterial based on the differences in their 16S rRNA genes. Amoeba is classified as an eukaryotes because, its cell is more developed than that of bacteria.
Many scientists never wear a lab coat at all. Some work in fields that don't require lab work and do their work behind a computer. Some use their science degrees to teach or write about science. Some work as consultants for companies, or as editors for scientific journals.
The correct answer would be “All of the Above”
Some ways would be to use less gas-powered items, such as some stoves. Communities can encourage carpools and walking. If you were to drive, don't gun the gas and drive at moderate speeds.
In your own home you can conserve energy by turning off lights and electronic devices when not in use. You could also use energy efficient light-bulbs.
Answer:
Abstract
Down syndrome (DS) is associated with aberrations in genetic, morphological, biochemical and physiological characteristics. A number of genes located on human chromosome 21 (HSA21) encode proteins which are thought to be involved in numerous metabolic pathways, e.g., phosphofructokinase, cystathionine β-synthase etc. Perturbations of the metabolic pathways may lead to altered drug metabolism in DS individuals. We present a review of metabolic aberrations linked to HSA21 genes in DS. We particularly focus on drug disposition, efficacy, sensitivity and toxicity of anti-leukaemic agents including methotrexate, glucocorticoids, anthracyclines and cytarabine in DS leukaemia. The different outcomes of therapy due to differential drug response, varied drug toxicity and treatment related mortality in DS leukaemia is a subject of much research and speculation. Altered drug response in DS individuals may stem from differences in pharmacokinetics, pharmacodynamics and pharmacogenetics. Further large-cohort studies in different age groups dissecting metabolic and molecular pathways involved in drug response may increase our understanding in this regard and stipulate pharmacotherapies in DS.